Roche Renews Focus On Sequencing With Genia Acquisition
Executive Summary
The deal, worth $125 million up front plus milestones, gives Roche a gateway into the emerging nanopore sequencing segment – the method is expected to “reduce the price of sequencing while increasing speed and sensitivity.”